Page last updated: 2024-08-16
rofecoxib and icg 001
rofecoxib has been researched along with icg 001 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Amerizadeh, F; Avan, A; Bahrami, A; Ghayour-Mobarhan, M; Hassanian, SM; Khazaei, M; Maftouh, M; Sadeghnia, HR; ShahidSales, S | 1 |
Reviews
1 review(s) available for rofecoxib and icg 001
| Article | Year |
|---|---|
Therapeutic Potential of Targeting Wnt/β-Catenin Pathway in Treatment of Colorectal Cancer: Rational and Progress.
Topics: Animals; Antineoplastic Agents; beta Catenin; Bridged Bicyclo Compounds, Heterocyclic; Cell Proliferation; Colorectal Neoplasms; Curcumin; Gene Expression Regulation, Neoplastic; Humans; Indoles; Lactones; Molecular Targeted Therapy; Pyrimidinones; Signal Transduction; Sulfones; Wnt Proteins | 2017 |